Skip to search formSkip to main contentSkip to account menu

CHF 1024

Known as: CHF-1024 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

5,6-dihydroxy-2-methyl-aminotetraline hydrochlorideTetrahydronaphthalenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Effect of beta-adrenergic and renin-angiotensin system blockade on myocyte apoptosis and oxidative stress in diabetic hypertensive rats.
2006
2006
Effects of the α2-Adrenergic/DA2-Dopaminergic Agonist CHF-1024 in Preventing Ventricular Arrhythmogenesis and Myocyte Electrical Remodeling, in a Rat Model of Pressure-Overload Cardiac Hypertrophy
Cardiac hypertrophy induces morpho-functional myocardial alterations favoring arrhythmogenesis, especially under specific… 
2003
2003
The Aminotetraline Derivative (±)-(R,S)-5,6-Dihydroxy-2-methylamino-1,2,3,4-tetrahydro-naphthalene Hydrochloride (CHF-1024) Displays Cardioprotection in Postischemic Ventricular Dysfunction of the…
To analyze the protective effects of the aminotetraline derivative (±)-(R,S)-5,6-dihydroxy-2-methylamino-1,2,3,4-tetrahydro… 
Review
2001
Review
2001
Dopaminergic Agents in Heart Failure: Rebirth of An Old Concept
Parenterally active dopaminergic compounds such as dopamine are widely used in low output syndromes and acute episodes or… 
1999
1999
Effects of a DA2/alpha2 agonist and a beta1-blocker in combination with an ACE inhibitor on adrenergic activity and left ventricular remodeling in an experimental model of left ventricular…
Renin-angiotensin-aldosterone and sympathetic nervous systems overactivity play a major role in worsening the extent of heart… 
1998
1998
Comparative efficacy of a DA2/alpha2 agonist and a beta-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery…
Attenuation of neuroendocrine activation may be beneficial in congestive heart failure. Sympathetic nervous system overactivity… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)